Aprepitant is a selective high-affinity antagonist at human substance P neurokinin 1 (NK1) receptors.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Aprepitant is the active ingredient of these drugs:
Germany
Austria
United States
Austria Brazil Canada Cyprus Finland
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):